Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Dirk Stenkamp"'
Autor:
Andreas Gollner, Markus Köster, Paul Nicklin, Thomas Trieselmann, Elliott Klein, Jaromir Vlach, Claudia Heine, Marc Grundl, Jürgen Ramharter, David Wyatt, Menorca Chaturvedi, Alessio Ciulli, Katharine C. Carter, Susanne Müller, Daniel Bischoff, Peter Ettmayer, Eric Haaksma, Jürgen Mack, Darryl McConnell, Dirk Stenkamp, Harald Weinstabl, Matthias Zentgraf, Clive R. Wood, Florian Montel
Publikováno v:
Nature reviews. Drug discovery. 21(7)
Autor:
Thorsten Lehmann, Ralf Lotz, Thorsten Oost, Mueller Stephan Georg, Klaus Rudolf, Dirk Stenkamp, Armin Heckel, Ralph Budzinski, Jörg Kley, Gerd-Michael Maier, Gerald Juergen Roth, Leo Thomas, Martin Lenter, Kirsten Arndt, Michael Markert
Publikováno v:
Bioorganicmedicinal chemistry letters. 25(16)
Although overweight and obesity are highly prevalent conditions, options to treat them are still very limited. As part of our search for safe and effective MCH-R1 antagonists for the treatment of obesity, two series of pyridones and pyridazinones wer
Autor:
Gerd-Michael Maier, Thorsten Lehmann, Ralf Lotz, Jörg Kley, Martin Lenter, Michael Markert, Mueller Stephan Georg, Kirsten Arndt, Philipp Lustenberger, Klaus Rudolf, Thorsten Oost, Armin Heckel, Marcus Schindler, Gerald Juergen Roth, Dirk Stenkamp
Publikováno v:
Bioorganicmedicinal chemistry letters. 25(16)
Despite recent approvals of anti-obesity drugs there is still a high therapeutic need for alternative options with higher efficacy in humans. As part of our MCH-R1 antagonist program for the treatment of obesity, a series of biphenylacetamide HTS hit
Autor:
Kirsten Arndt, Ralf Lotz, Klaus Rudolf, Thorsten Lehmann, Mueller Stephan Georg, Ralph Budzinski, Gerald Juergen Roth, Leo Thomas, Martin Lenter, Dirk Stenkamp, Armin Heckel, Thorsten Oost, Marcus Schindler, Jörg Kley
Publikováno v:
Bioorganicmedicinal chemistry letters. 25(16)
Despite recent success there remains a high therapeutic need for the development of drugs targeting diseases associated with the metabolic syndrome. As part of our search for safe and effective MCH-R1 antagonists for the treatment of obesity, a serie
Publikováno v:
Angewandte Chemie International Edition. 41:4573-4576
In the preceding communication,[1] the proposed synthesis plan identified the two principal pectenotoxin-4 subunits II and III (Figure 1). It was our intention to couple these fragments through the alkylation of the metalloenamine derived from hydraz
Publikováno v:
Angewandte Chemie International Edition. 41:4569-4573
The first members of the pectenotoxin family of marine natural products were isolated off the northeastern coast of Japan in 1985. Subsequently, ten members of this group have been identified.[1] The structural diversity within the pectenotoxins stem
Autor:
Heike A. Wieland, Henri Doods, Richard M. Söll, Annette G. Beck-Sickinger, Bärbel Lämmle, Dirk Stenkamp, Rudolf Hurnaus
Publikováno v:
European Journal of Biochemistry. 269:1128-1135
I-labelled orexin B from the recombinant orexin 1receptor stablyexpressedinChinesehamsterovarycells.Toexaminetheroleoftheshortenedorexin A23–33infeeding,its effects in mimicking or antagonizing the effects of orexinA were studied in rats after ad
Publikováno v:
European Journal of Organic Chemistry. 1999:2929-2936
Publikováno v:
European Journal of Organic Chemistry. 1999:2915-2927
2,4-Disubstituted pentanes are molecules which adopt essentially only two conformations. Substituents have been varied in order to find those which lead to a strong preference of the conformer equilibrium. Studying 2-substituted 4-methylpentanes 3 an
Autor:
Dirk Stenkamp, Reinhard W. Hoffmann
Publikováno v:
Tetrahedron. 55:7169-7176
The preference of (2R∗,4r∗,6S∗)-2,4,6-trichloroheptane ( 6 ) for populating the fully extended conformation mirrors the local conformational preferences of the 2,4-dichloropentane subunits. Likewise, the preference of (2R∗,4r∗,6S∗)-2,6-di